421 results match your criteria: "Joint Research Center for Human Retrovirus Infection.[Affiliation]"

Antiviral humoral immunity induced by JN.1 monovalent mRNA vaccines against SARS-CoV-2 omicron subvariants including JN.1, KP.3.1.1, and XEC.

Lancet Infect Dis

December 2024

Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan; International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan; International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan; Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Japan; Collaboration Unit for Infection, Joint Research Center for Human Retrovirus infection, Kumamoto University, Kumamoto, Japan; MRC-University of Glasgow Centre for Virus Research, Glasgow, UK. Electronic address:

View Article and Find Full Text PDF
Article Synopsis
  • * It finds that the frequency of SIV-Gag-specific follicular CD8 T cells is linked to the amount of SIV-RNA, particularly in treated or naturally controlling macaques, while showing a different behavior in untreated macaques.
  • * The research indicates that the gene expression profile of fCD8 T cells in naturally controlled infections is more favorable compared to those under cART, suggesting that improving these cells may lead to potential curative strategies for HIV/SIV.
View Article and Find Full Text PDF

Adult T-cell leukemia/lymphoma (ATLL) is a refractory blood cancer with severe immunodeficiency resulting from retroviral infection. ATLL develops in only 5 % of HTLV-1-infected individuals, but the entire mechanism of ATLL progression remains unknown. Since recent studies have reported that the gut microbiome influences the progression of various diseases, we hypothesized that ATLL is also related to the gut microbiome and aimed to investigate this relationship.

View Article and Find Full Text PDF

Continuing progress in radioimmunotherapy for hematologic malignancies.

Blood Rev

November 2024

Division of Hematopoiesis, Joint Research Center for Human Retrovirus Infection, Kumamoto University, 2-2-1 Honjo, Chuo-ku, Kumamoto 860-0811, Japan. Electronic address:

Article Synopsis
View Article and Find Full Text PDF

The persistence of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the emergence of new mutant strains continue to present a substantial threat with potential for future pandemics. Safe, effective, and readily available COVID-19 therapeutics are urgently needed to prepare for future coronavirus pandemics. To help identify new antiviral agents, the present study focused on natural products in the extracts of Holy Basil, Ocimum tenuiflorum L.

View Article and Find Full Text PDF

Unlabelled: Enzootic bovine leukosis (EBL), although eradicated in some European countries, is still the most common neoplastic disease of cattle, caused by the bovine leukemia virus (BLV). During the progression of EBL, BLV-infected cells clonally expand, and some of which result in tumor onset. The clonality of BLV-infected cells is generally evaluated with NGS or Sanger sequencing.

View Article and Find Full Text PDF

Antiviral immune response against HTLV-1 invalidates T-SPOT.TB results in patients with HTLV-1-positive rheumatic diseases.

Front Immunol

November 2024

Division of Respirology, Rheumatology, Infectious Diseases and Neurology, Department of Internal Medicine, University of Miyazaki, Miyazaki, Japan.

Background: T-SPOT.TB, one of the screening tests for latent tuberculosis infection (LTBI), yields invalid results in human T-cell leukemia virus type 1 (HTLV-1)-positive patients with rheumatoid arthritis. However, the detailed mechanisms behind this invalidation are unclear.

View Article and Find Full Text PDF

Virological characteristics of the SARS-CoV-2 XEC variant.

Lancet Infect Dis

December 2024

Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Graduate School of Frontier Sciences, The University of Tokyo, Chiba, Japan; Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Collaboration Unit for Infection, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan; International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; MRC-University of Glasgow Centre for Virus Research, Glasgow, UK. Electronic address:

View Article and Find Full Text PDF

​Purpose The purpose of this study was to evaluate the capabilities of large language models (LLMs) in understanding radiation safety and protection. We assessed the performance of generative pe-trained transformer (GPT)-4 (OpenAI, USA) and Gemini Advanced (Google DeepMind, London) using questions from the First-Class Radiation Protection Supervisor Examination in Japan. Methods The study involved GPT-4 and Gemini Advanced answering questions from the 68th First-Class Radiation Protection Supervisor Examination in Japan.

View Article and Find Full Text PDF

Primary care and sexual health services for transgender people in Japan are lacking. We surveyed 233 transgender patients (57 [24.5%] assigned male at birth [AMABs] and 176 [75.

View Article and Find Full Text PDF

Induction of IGHV3-53 public antibodies with broadly neutralising activity against SARS-CoV-2 including Omicron subvariants in a Delta breakthrough infection case.

EBioMedicine

December 2024

Collaborative Research Program with the Chemo-Sero-Therapeutic Research Institute for Anti-viral Agents and Hematological Diseases, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan. Electronic address:

Background: Emergence of SARS-CoV-2 variants that escape neutralising antibodies hampers the development of vaccines and therapeutic antibodies against SARS-CoV-2. IGHV3-53/3-66-derived public antibodies, which are generally specific to the prototype virus and are frequently induced in infected or vaccinated individuals, show minimal affinity maturation and high potency against prototype SARS-CoV-2.

Methods: Monoclonal antibodies isolated from a Delta breakthrough infection case were analysed for cross-neutralising activities against SARS-CoV-2 variants.

View Article and Find Full Text PDF

Background/aim: Aberrant activation of the Wnt/β-catenin signaling pathway contributes to the pathogenesis of acute myelogenous leukemia (AML). Thus, targeting this pathway offers a promising therapeutic strategy against AML. Here, we synthesized a novel dipeptide-type inhibitor of the Wnt/β-catenin signaling pathway, compound #41, and explored its anti-tumor effects on AML cells.

View Article and Find Full Text PDF

Magnetic nanoparticles: An emerging nanomedicine for cancer immunotherapy.

Prog Mol Biol Transl Sci

October 2024

Department of Biochemistry, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand; Center for Translational Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand. Electronic address:

Cancer immunotherapy is a revolutionised strategy that strikingly improves cancer treatment in recent years. However, like other therapeutic modalities, immunotherapy faces several challenges and limitations. Many methods have been developed to overcome those limitations; thus, nanomedicine is one of the emerging fields with a highly promising application.

View Article and Find Full Text PDF

3,3'-Diindolylmethane (DIM), a compound derived from natural fruits and vegetables, is widely recognized for its anti-cancer activity. However, its action mechanisms remain ambiguous. In this study, to study the molecular mechanism of 3,3'-Diindolylmethane, we identified a novel mutation in the gene of mitochondrial translation elongation factor EF-Ts (tsf1), a key factor in mitochondrial protein translation, that conferred DIM resistance to Schizosaccharomyces pombe.

View Article and Find Full Text PDF
Article Synopsis
  • The MR1 molecule is a specialized antigen presenter that interacts with T cells, particularly mucosal-associated invariant T (MAIT) cells, by presenting various metabolites.
  • Researchers discovered distinct MR1-restricted T cell receptors (TCRs) in tumor-infiltrating lymphocytes from breast cancer patients, which responded specifically to certain breast cancer cell lines but not others.
  • The study indicates that these TCRs can recognize antigens in breast cancer without being affected by a known MR1 ligand antagonist, suggesting a unique interaction that relies on a specific residue of MR1 (K43).
View Article and Find Full Text PDF

High plasma concentration of tenofovir alafenamide in people living with HIV with ABCB1 genetic variants.

J Infect Chemother

October 2024

AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan; The Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan. Electronic address:

Objectives: We aimed to analyze the relationships between single nucleotide polymorphisms in the ATP-binding cassette transporter B1 (ABCB1) and G2 (ABCG2) genes and plasma concentrations of tenofovir alafenamide (TAF), tenofovir (TFV), and emtricitabine (FTC).

Methods: We recruited 10 people living with HIV receiving once-daily treatment with a single tablet containing TAF (25 mg), FTC (200 mg), and bictegravir (50 mg). Peripheral blood samples were collected at 0, 1, 2, 3, 4, 6, 8, 12, and 24 h after administration.

View Article and Find Full Text PDF

Hippo pathway in cancer cells induces NCAM1αSMA fibroblasts to modulate tumor microenvironment.

Commun Biol

October 2024

Department of Molecular and Medical Pharmacology, Faculty of Life Sciences, Kumamoto University, Kumamoto, 860-8556, Japan.

Cancer cells adeptly manipulate the tumor microenvironment (TME) to evade host antitumor immunity. However, the role of cancer cell-intrinsic signaling in shaping the immunosuppressive TME remains unclear. Here, we found that the Hippo pathway in cancer cells orchestrates the TME by influencing the composition of cancer-associated fibroblasts (CAFs).

View Article and Find Full Text PDF
Article Synopsis
  • Since 2019, SARS-CoV-2 has mutated, leading to various pandemic and epidemic waves that involve changes in its spike protein, which is key for the virus's entry into cells.
  • Researchers studied the spike proteins from variants BA.2.86 and JN.1, discovering structures where ACE2 receptor binds to the spike protein in both up and down conformations.
  • Their findings suggest that the down-conformation of the receptor-binding domain (RBD) is an important intermediate state that helps facilitate the virus's entry, with specific mutations like K356T impacting infectivity and resistance to neutralizing antibodies.
View Article and Find Full Text PDF

Targeted immune cell therapy for hepatocellular carcinoma using expanded liver mononuclear cell-derived natural killer cells.

Neoplasia

December 2024

Laboratory of Transplantation Immunology, National Research Institute for Child Health and Development, Tokyo, Japan; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, PR China. Electronic address:

Article Synopsis
  • Natural killer (NK) cells show potential as therapy for hard-to-treat cancers like hepatocellular carcinoma (HCC), but are often dysfunctional in HCC patients.
  • This study introduces LMNC-NK cells, derived from liver graft perfusate, which are more plentiful and exhibit enhanced cytotoxic properties compared to traditional NK cells from peripheral blood.
  • Through extensive gene analysis, the research highlights significant differences in gene expression that contribute to LMNC-NK cells’ superior effectiveness against HCC, suggesting their use as a promising treatment option.
View Article and Find Full Text PDF

Cancer stem cells (CSC) play an important role in carcinogenesis and are acknowledged to be responsible for chemoresistance in cholangiocarcinoma (CCA). Studying CCA CSC has been challenging, due to lack of consensus CSC markers, and to their plastic nature. Since dual expression of the core pluripotent factors SOX2/OCT4 has been shown to correlate with poor outcome in CCA patients, we selected the SOX2/OCT4 activating short half-life GFP-based live reporter (SORE6-dsCopGFP) to study CSC dynamics at the single-cell level.

View Article and Find Full Text PDF

Facilitating cholangiocarcinoma inhibition by targeting CD47.

Exp Mol Pathol

December 2024

Division of Hematopoiesis, Joint Research Center for Human Retrovirus Infection and Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-0811, Japan. Electronic address:

Immune evasion is one of the mechanisms by which cancer cells acquire immunity during cancer development and progression. One of these is the increased expression of cluster of differentiation 47 (CD47), a transmembrane glycoprotein that protects cells from phagocytic elimination. The interaction between CD47 and signal regulatory protein alpha (SIRPα) on macrophages alleviates the phagocytic signal.

View Article and Find Full Text PDF
Article Synopsis
  • * A new vaccine, ChAdOx1.COVconsv12, was created to enhance the immune response by targeting conserved viral regions, aiming to provide broader protection against various sarbecoviruses, including new variants of SARS-CoV-2.
  • * In studies with mice and Syrian hamsters, while ChAdOx1.COVconsv12 alone didn't prevent SARS-CoV-2 infection, it improved recovery and reduced viral load when given alongside a smaller dose of the spike vaccine, indicating potential benefits
View Article and Find Full Text PDF

Evaluating the Use of Sacran, a Polysaccharide Isolated from , as a Possible Microbicide for Preventing HIV-1 Infection.

Viruses

September 2024

Division of Hematopoiesis, Joint Research Center for Human Retrovirus Infection, Kumamoto University, 2-2-1 Honjo, Chuo-ku, Kumamoto 860-0811, Japan.

Article Synopsis
  • Sacran is a special substance that comes from a type of blue-green algae and can help protect against HIV, a virus that causes AIDS.
  • Since a new treatment for HIV was created, fewer people are dying from AIDS, but the virus is still spreading through sexual contact.
  • The study showed that sacran can stop HIV from spreading and might work even better when used with other HIV medicines.
View Article and Find Full Text PDF